Africa Strategy
CARE9’s Africa operations focus on building sustainable, sovereign healthcare infrastructure across the continent, starting with Ghana and ECOWAS nations and expanding pan-continentally.
Ghana & ECOWAS: Flagship Market
Landmark Joint Venture: CARE9 x DIHOC x GMTF
In February 2026, CARE9 Global formalized a joint venture with the Defence Industries Holding Company Limited (DIHOC), the Ghana Armed Forces (GAF), and the Ghana Medical Trust Fund (GMTF) to construct a comprehensive cancer and multi-specialty healthcare facility in Ghana.
The Ghana Armed Forces presented proposals for oncology facilities, including a specialized cancer treatment hospital, diagnostics and research services, and a technology-driven pharmaceutical supply chain model. The GMTF confirmed its openness to exploring partnership opportunities as the facility becomes operational, creating a direct government financing pathway for cancer patients through MahamaCare.
Strategic Partners
DIHOC (Defence Industries Holding Company Limited)
- 100% owned by Ghana Armed Forces and Ministry of Defence
- Sovereign institutional backing, land access, regulatory facilitation
- Integration with Ghana’s military healthcare network (37 Military Hospital)
- 12 active joint venture companies across strategic sectors
Ghana Medical Trust Fund (GMTF / MahamaCare)
- Government financing vehicle for cancer and non-communicable diseases
- Direct payor pathway removing out-of-pocket barriers for patients
- Confirmed alignment on partnership as facility becomes operational
Ghana Armed Forces (GAF)
- Active co-developer presenting oncology facility proposals
- Institutional capacity in construction, security, and operations
- Healthcare network including the 400 bed 37 Military Hospital
Ghana Ministry of Health
- National healthcare infrastructure development
- Policy alignment and regulatory coordination
- Public health program integration
NHIA (National Health Insurance Authority)
- Insurance scheme integration (20+ million active members)
- Long-term procurement agreements
- Claim processing automation
Ghana FDA
- Pharmaceutical registration and approval
- WHO Maturity Level 3 status for pharmaceutical regulation
- Quality assurance coordination
Flagship Initiatives
1. Comprehensive Cancer and Multi-Specialty Healthcare Facility
Status: Joint venture confirmed, February 2026
Infrastructure:
- 250 bed tertiary oncology hospital with multi-specialty capabilities
- 2 Linear Accelerators (LINACs) for radiation therapy
- PET-CT and advanced imaging
- Molecular oncology laboratory
- Tele-oncology platform
- Technology-driven pharmaceutical supply chain
Impact Projections:
- 100,000+ Patients screened annually
- 10,000+ New cancer cases treated per year
- 30-40% Reduction in outbound medical travel
- 1,000+ Direct jobs created
- $50M+ Annual reduction in medical travel expenditure
- National Cancer registry establishment
2. Pharmaceutical Manufacturing Hub
Investment: $150-200M
Capabilities:
- WHO-GMP certified manufacturing facility
- Oncology injectables production
- Critical care pharmaceuticals
- IV fluids and sterile injectables
- Export readiness for ECOWAS markets
Import Substitution:
- USD 150-200M Annual import substitution
- 60-70% Essential medicines list coverage
- 1500+ Direct manufacturing jobs
- 5000+ Indirect supply chain jobs
Regulatory Compliance:
- Ghana FDA approval
- WHO Prequalification pathway
- ECOWAS WA-MRH harmonization
- Export documentation for AfCFTA
3. Diagnostics Network Development
Hub-and-Spoke Model
Central Hubs (Accra, Kumasi, Takoradi):
- Advanced imaging (CT, MRI, PET-CT)
- Molecular diagnostics (PCR, NGS)
- Reference laboratory services
- Tele-radiology and tele-pathology
Spoke Sites (15-20 locations):
- Basic pathology and radiology
- Sample collection and transport
- Report delivery integration
- Training and quality control
Capacity Building:
- 200+ Radiologists and pathologists trained
- 500+ Laboratory technicians certified
- CARE9 Diagnostic Academy establishment
- Continuous professional development programs
ECOWAS Regional Expansion
Target Countries:
- Nigeria (Lagos, Abuja, Kano)
- Côte d’Ivoire (Abidjan)
- Senegal (Dakar)
- Togo, Benin, Burkina Faso
Regional Services:
- Pharmaceutical distribution network
- HIMS deployments across 250+ facilities
- Diagnostic reference laboratories
- Training and certification programs
Trade Integration:
- AfCFTA (African Continental Free Trade Area) alignment
- ECOWAS WA-MRH regulatory harmonization
- Cross-border pharmaceutical trade
- Regional healthcare workforce mobility
Beyond ECOWAS: Pan-African Expansion
Southern Africa
Zimbabwe
- Harare: 250-bed oncology institute (planned)
- Manufacturing: Pharmaceutical production facility
- HIMS: 50+ hospital deployments
Zambia
- Lusaka: Diagnostic network hub
- Oncology: LINAC installation and services
- Training: Regional oncology academy
Namibia, Botswana
- Diagnostic services expansion
- Pharmaceutical distribution
- Telemedicine infrastructure
Eastern Africa
Kenya
- Nairobi: Regional diagnostic hub
- HIMS Deployments: Private and public hospitals
- NHIF Integration: National health insurance coordination
Uganda, Tanzania
- Pharmaceutical supply chain
- Hospital digitization programs
- Specialty care partnerships
Central Africa
DR Congo, Cameroon
- EPC+O Models: Engineering, Procurement, Construction + Operations
- Specialty Hospitals: Oncology and cardiology focus
- Training Academies: Healthcare workforce development
Africa Impact Metrics (Projected by 2030)
Infrastructure
- 1000+ Oncology beds commissioned
- 10+ Manufacturing and diagnostic facilities
- 250+ Hospitals with CARE9 HIMS
- 20+ Training academies operational
Economic Impact
- USD 250M+ Import substitution value
- USD 200M+ Annual pharmaceutical exports
- 10,000+ Direct jobs created
- 50,000+ Indirect jobs supported
Healthcare Outcomes
- 500,000+ Patients served annually
- 30-40% Reduction in medical travel
- 1M+ Cancer screenings conducted
- 5000+ Healthcare workers trained
Market Penetration
- 10+ ECOWAS countries operational
- 40+ African countries export reach
- 500+ Healthcare institutions in network
Regulatory & Compliance Framework
National Regulatory Authorities
- Ghana FDA (Food and Drugs Authority)
- NAFDAC (Nigeria)
- SAHPRA (South Africa)
- Country-specific drug authorities
Regional Frameworks
- ECOWAS WA-MRH: West African Medicines Regulatory Harmonization
- AfCFTA: Continental free trade protocols
- AU-NEPAD: African Union health initiatives
- EAC: East African Community standards
International Standards
- WHO Good Manufacturing Practice (GMP)
- WHO Prequalification Programme
- IAEA (Radiological safety)
- CAP (Laboratory accreditation)
Partnerships & Stakeholders
Government Agencies
- Ministries of Health
- National Health Insurance Authorities
- Drug Regulatory Authorities
- Investment Promotion Agencies
Development Finance Institutions
- African Development Bank (AfDB)
- International Finance Corporation (IFC)
- DEG (German DFI)
- Proparco (French DFI)
- TDB (Trade and Development Bank)
Multilateral Organizations
- World Health Organization (WHO)
- African Union Commission
- UNAIDS, Global Fund, GAVI
- Bill & Melinda Gates Foundation
Local Partners
- Hospital chains and health systems
- Medical universities and training institutes
- Pharmaceutical distributors
- Medical equipment suppliers
ESG Commitments in Africa
Environmental
- Solar-powered healthcare facilities
- Water conservation in manufacturing
- Biomedical waste management
- Green building standards
Social
- Local hiring mandates (80%+ African workforce)
- Skills development and training
- Women in healthcare leadership programs
- Community health initiatives
Governance
- Transparent procurement processes
- Anti-corruption compliance
- Local content requirements
- Ethical clinical research practices
Next Steps for African Partners
- Country Assessment: Healthcare needs and infrastructure gaps
- Partnership Models: PPP, BOOT, BOT structuring
- Regulatory Pathway: Approvals and licensing roadmap
- Financial Structuring: DFI engagement and capital raising
- Implementation: Design, construction, operations launch
Contact CARE9 Africa: africa@care9.com Accra Office: Regional Command Center, Ghana